Skip to search formSkip to main contentSkip to account menu

OctreoTher

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

yttrium Y 90-DOTA-tyr3-octreotide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
[Metabolic radiotherapy for gastroenteropancreatic endocrine tumors using radiolabeled somatostatin].
Surgery is the only curative treatment of gastro-entero-pancreatic endocrine tumors. In inoperable or metastasized forms… 
2006
2006
Radiothérapie métabolique des tumeurs endocrines gastro-entéro-pancréatiques par les analogues radio-marqués de la somatostatine
Review
2000
Review
2000
OctreoTherTM: Ongoing Early Clinical Development of a Somatostatin-Receptor-Targeted Radionuclide Antineoplastic Therapy
OctreoTherTM (90Y-DOTA-D-Phe1-Tyr3-octreotide, a.k.a. 90Y-SMT 487) consists of a somatostatin peptide analogue (Tyr3-octreotide… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)